AIT LABORATORIES
DEAD

Serial Number

77344755

Owner

American Institute of Toxicology, Inc.

Attorney

William S. Fultz

First Use Date

May 17, 1993

Filing Date

Dec 5, 2007

Add to watchlist:

No watchlists yet
View on USPTO

AIT LABORATORIES Trademark

Serial Number: 77344755 • Registration: 3645544

AIT LABORATORIES is a trademark filed by American Institute of Toxicology, Inc. on December 5, 2007. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently no longer active.

Owner Contact Info

American Institute of Toxicology, Inc. (15 trademarks)

2265 Executive Drive, Suite A
Indianapolis, IN 46241

Entity Type: 03

Trademark Details

Filing Date

December 5, 2007

Registration Date

June 30, 2009

First Use Anywhere

May 17, 1993

First Use in Commerce

May 17, 1993

Published for Opposition

April 14, 2009

Cancellation Date

February 7, 2020

Goods & Services

[ examination of fingerprints for the purpose of forensic scientific intelligence; ] expert witness services in legal matters in the field of in criminal and civil proceedings involving forensic toxicology and controlled substances, trace evidence and chemical hazard detection in food, drink and consumer products

Consulting services in the field of forensic examination of victims of crime; drug testing for substance abuse, namely, forensic substance abuse testing

[ Materials testing and evaluation, namely, providing evaluation testing for pharmaceutical, biopharmaceutical and chemical concentrations and compositions; materials testing and evaluation, namely, pre-clinical and non-clinical evaluation testing of pharmaceutical, biopharmaceutical and chemical products; pharmaceutical, biopharmaceutical, and chemical research and development for others; ] Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; Performing scientific research or providing scientific research services to identify the most informative, effective and efficient panels of biomarkers to aid in the new drug development and clinical trial process; Scientific research and development, namely, providing biomarker-related technical consulting, scientific research, assay development, and testing services to support new drug development and clinical trials; Conducting scientific research related to the discovery and identification of novel biomarkers of interest; [ Providing scientific research services to pharmaceutical companies, Contract Research Organizations (CROs), and diagnostic testing companies to support the integration of biomarker assays into clinical trials and new drug/product codevelopment efforts; Custom design and development of biochemical assays, including multiplexed assays, to assist with pre-clinical drug development and pharmacokinetic and pharmacodynamic scientific studies; and to assist with clinical trials to evaluate clinical trial safety, efficacy, toxicology, and dosing; ] Consulting services in the field of collection of evidence for forensic purposes; Forensic toxicology, namely, consulting services in the field of collection of evidence for forensic purposes; providing information in the field of collection of evidence for forensic purposes, namely, identification, assays and origin elucidations of controlled substances and the physical and chemical comparisons, individualizations and identifications of trace evidence; Performance of chemical analyses, namely, chemical hazard detection in food, drink and consumer products; [ Environmental testing and inspection services, namely, environmental and community toxicology; ] clinical toxicology; bioanalytical pharmacology; development, modification, applications and validation of analytical method advances for emerging medicinal [ and environmental foreign compound analytes ] and biomarkers

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Feb 7, 2020 CAEX
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jun 30, 2018 REM2
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 3, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 3, 2016 REAP
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jul 24, 2015 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jul 24, 2015 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 23, 2015 APRE
TEAS SECTION 8 & 15 RECEIVED
Jun 29, 2015 E815
WITHDRAWAL OF ATTORNEY GRANTED
Nov 27, 2012 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Nov 27, 2012 WOAR
REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
May 14, 2012 CORV
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
May 4, 2012 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 24, 2011 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 24, 2011 REAP
REGISTERED-PRINCIPAL REGISTER
Jun 30, 2009 R.PR
PUBLISHED FOR OPPOSITION
Apr 14, 2009 PUBO
NOTICE OF PUBLICATION
Mar 25, 2009 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 7, 2009 PREV
ASSIGNED TO LIE
Mar 7, 2009 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 6, 2009 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 6, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 6, 2009 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 6, 2009 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 20, 2008 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 20, 2008 GNSL
SUSPENSION LETTER WRITTEN
Oct 20, 2008 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 29, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 28, 2008 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 28, 2008 TROA
PETITION TO REVIVE-GRANTED
Sep 28, 2008 PETG
TEAS PETITION TO REVIVE RECEIVED
Sep 28, 2008 PROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 19, 2008 GNRN
NON-FINAL ACTION E-MAILED
Mar 19, 2008 GNRT
NON-FINAL ACTION WRITTEN
Mar 19, 2008 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 19, 2008 GNRN
NON-FINAL ACTION E-MAILED
Mar 19, 2008 GNRT
NON-FINAL ACTION WRITTEN
Mar 19, 2008 CNRT
ASSIGNED TO EXAMINER
Mar 14, 2008 DOCK
NOTICE OF PSEUDO MARK MAILED
Dec 11, 2007 MPMK
NEW APPLICATION ENTERED
Dec 10, 2007 NWAP